PECAM-1 and gelatinase B coexist in vascular cuffs of multiple sclerosis lesions

Neuropathology and Applied Neurobiology

Volumn 32, Issue 1, 2006, Pages 15-22

  Nelissen, I ^a   Gveric, D ^b   Van Noort, J M ^c   Cuzner, M L ^b   Opdenakker, G ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c TNO   (Netherlands)

Author keywords

Immunohistochemistry; MMP 7; MMP 9; Multiple sclerosis; PECAM 1

Indexed keywords

CD31 ANTIGEN; GELATINASE B; MATRILYSIN;

ARTICLE; AUTOPSY; BLOOD ANALYSIS; BRAIN; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME DEGRADATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; CELL MOTION; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANTIGENS, CD31; BLOTTING, WESTERN; BRAIN; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; MATRIX METALLOPROTEINASE 9; MULTIPLE SCLEROSIS;

EID: 33644898153     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00677.x     Document Type: Article

References (24)

1. Newman PJ The biology of PECAM-1 J Clin Invest 1997 99 3 8
2. Losy J Niezgoda A Wender M Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions J Neuroimmunol 1999 99 169 72
3. Niezgoda A Losy J Pecam-1 expression in patients with relapsing-remitting multiple sclerosis Folia Morph (Warsz 2002 61 143 5
4. Liao F Huynh HK Eiroa A Greene T Polizzi E Muller WA Migration of monocytes across endothelium and passage through extracellular matrix involve separate domains of PECAM-1 J Exp Med 1995 182 1337 43
5. Graesser D Solowiej A Bruckner M Osterweil E Juedes A Davis S Ruddle NH Engelhardt B Madri JA Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice J Clin Invest 2002 109 383 92
6. Mun-Bryce S Rosenberg GA Gelatinase B modulates selective opening of the blood-brain barrier during inflammation Am J Physiol 1998 274 R1203 11
7. Cuzner ML Opdenakker G Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system J Neuroimmunol 1999 94 1 14
8. Kouwenhoven M Ozenci V Gomes A Yarilin D Giedraitis V Press R Link H Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes J Autoimmun 2001 16 463 70
9. Cossins JA Clements JM Ford J Miller KM Pigott R Vos W Van der Valk P De Groot CJ Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions Acta Neuropathol (Berl) 1997 94 590 8
10. Cuzner ML Gveric D Strand C Loughlin AJ Paemen L Opdenakker G Newcombe J The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution J Neuropathol Exp Neurol 1996 55 1194 204
11. Proost P Van Damme J Opdenakker G Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein Biochem Biophys Res Commun 1993 192 1175 81
12. Chandler S Coates R Gearing A Lury J Wells G Bone E Matrix metalloproteinases degrade myelin basic protein Neurosci Lett 1995 201 223 6
13. Fiore E Fusco C Romero P Stamenkovic I Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity Oncogene 2002 21 5213 23
14. Ilan N Mohsenin A Cheung L Madri JA PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics FASEB J 2001 15 362 72
15. Van den Steen PE Proost P Wuyts A Van Damme J Opdenakker G Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact Blood 2000 96 2673 81
16. Paemen L Martens E Masure S Opdenakker G Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity Eur J Biochem 1995 234 759 65
17. Gveric D Cuzner ML Newcombe J Insulin-like growth factors and binding proteins in multiple sclerosis plaques Neuropathol Appl Neurobiol 1999 25 215 25
18. Gveric D Herrera B Petzold A Lawrence DA Cuzner ML Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors Brain 2003 126 1590 8
19. Goldberger A Middleton KA Oliver JA Paddock C Yan HC DeLisser HM Albelda SM Newman PJ Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form J Biol Chem 1994 269 17183 91
20. Van Ranst M Norga K Masure S Proost P Vandekerckhove F Auwerx J Van Damme J Opdenakker G The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers Cytokine 1991 3 231 9
21. Nelissen I Ronsse I Van Damme J Opdenakker G Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta J Leukoc Biol 2002 71 89 98
22. Sun J Williams J Yan HC Amin KM Albelda SM DeLisser HM Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression J Biol Chem 1996 271 18561 70
23. Cepinskas G Savickiene J Ionescu CV Kvietys PR PMN transendothelial migration decreases nuclear NFkappaB in IL-1beta-activated endothelial cells: role of PECAM-1 J Cell Biol 2003 161 641 51
24. Van den Steen PE Dubois B Nelissen I Rudd PM Dwek RA Opdenakker G Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9) Crit Rev Biochem Mol Biol 2002 37 375 536